Asia Pacific Liver Cancer Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Analysis – by Type (Laboratory Tests, Endoscopy, Imaging, Biopsy, and Others) and End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, and CRO Laboratories)

No. of Pages: 138    |    Report Code: BMIRE00025040    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Liver Cancer Diagnostics Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Liver Cancer Diagnostics Market – By Type

1.3.2        Asia Pacific Liver Cancer Diagnostics Market – By End User

1.3.3        Asia Pacific Liver Cancer Diagnostics Market – By Country

2.           Asia Pacific Liver Cancer Diagnostics Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Liver Cancer Diagnostics Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Experts Opinion

5.           Asia Pacific Liver Cancer Diagnostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Liver Cancer

5.2         Market Restraints

5.2.1        Extensive Cost of Technologically Advanced Liver Cancer Diagnostic Solutions

5.3         Market Opportunities

5.3.1        Surging Demand for Point-of-Care Testing

5.4         Future Trends

5.4.1        Growing Emergence of New Technologies

5.5         Impact Analysis

6.           Asia Pacific Liver Cancer Diagnostics Market Analysis

6.1         Asia Pacific Liver Cancer Diagnostics Market Revenue Forecast and Analysis

7.           Asia Pacific Liver Cancer Diagnostics Market Analysis By Type

7.1         Overview

7.2         Asia Pacific Liver Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)

7.3         Laboratory Tests

7.3.1        Overview

7.3.2        Laboratory Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1          Blood Tests

7.3.2.1.1          Overview

7.3.2.1.2          Blood Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2          Biomarkers

7.3.2.2.1          Overview

7.3.2.2.2          Biomarkers: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Endoscopy

7.4.1        Overview

7.4.2        Endoscopy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Imaging

7.5.1        Overview

7.5.2        Imaging: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Biopsy

7.6.1        Overview

7.6.2        Biopsy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7         Others

7.7.1        Overview

7.7.2        Others: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           Asia Pacific Liver Cancer Diagnostics Market Analysis – By End User

8.1         Overview

8.2         Asia Pacific Liver Cancer Diagnostics Market Revenue Share, By End User (2021 and 2028)

8.3         Hospitals and Diagnostics Laboratories

8.3.1        Overview

8.3.2        Hospitals and Diagnostics Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Academic and Research Institutes

8.4.1        Overview

8.4.2        Academic and Research Institutes: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5         CRO Laboratories

8.5.1        Overview

8.5.2        CRO Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           Asia Pacific Liver Cancer Diagnostics Market – Country Analysis

9.1         Overview

9.1.1        Asia-Pacific: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

9.1.1.1          China: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.1          Overview

9.1.1.1.2          China: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.2.1        China: Liver Cancer Diagnostics Market, by Type- 2019–2028 (USD Million)

9.1.1.1.2.2        China: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019–2028 (USD Million)

9.1.1.1.3          China: Liver Cancer Diagnostics Market, by End User- 2019–2028 (USD Million)

9.1.1.2          Japan: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.1          Overview

9.1.1.2.2          Japan: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.3          Japan: Liver Cancer Diagnostics Market, by Type- 2019–2028 (USD Million)

9.1.1.2.3.1        Japan: Liver Cancer Diagnostics Market, by Laboratory Tests- 2019–2028 (USD Million)

9.1.1.2.4          Japan: Liver Cancer Diagnostics Market, by End User- 2019–2028 (USD Million)

9.1.1.3          India: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.1          Overview

9.1.1.3.2          India: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.3          India: Liver Cancer Diagnostics Market, by Type- 2019–2028 (USD Million)

9.1.1.3.3.1        India: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019–2028 (USD Million)

9.1.1.3.4          India: Liver Cancer Diagnostics Market, by End User- 2019–2028 (USD Million)

9.1.1.4          South Korea: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4.1          Overview

9.1.1.4.2          South Korea: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4.3          South Korea: Liver Cancer Diagnostics Market, by Type- 2019–2028 (USD Million)

9.1.1.4.3.1        South Korea: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019–2028 (USD Million)

9.1.1.4.4          South Korea: Liver Cancer Diagnostics Market, by End User- 2019–2028 (USD Million)

9.1.1.5          Australia: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.5.1          Overview

9.1.1.5.2          Australia: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.5.3          Australia: Liver Cancer Diagnostics Market, by Type- 2019–2028 (USD Million)

9.1.1.5.3.1        Australia: Liver Cancer Diagnostics Market, by Laboratory Tests- 2019–2028 (USD Million)

9.1.1.5.4          Australia: Liver Cancer Diagnostics Market, by End User- 2019–2028 (USD Million)

9.1.1.6          Rest of APAC: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.6.1          Overview

9.1.1.6.2          Rest of APAC: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.6.3          Rest of APAC: Liver Cancer Diagnostics Market, by Type- 2019–2028 (USD Million)

9.1.1.6.3.1        Rest of APAC: Liver Cancer Diagnostics Market, by Laboratory Tests - 2019–2028 (USD Million)

9.1.1.6.3.2        Rest of APAC: Liver Cancer Diagnostics Market, by End User- 2019–2028 (USD Million)

10.        Asia Pacific Liver Cancer Diagnostics Market– Industry Landscape

10.1      Overview

10.2      Organic Developments

10.2.1     Overview

10.3      Inorganic Developments

10.3.1     Overview

11.        Company Profiles

11.1      Abbott

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      bioMerieux SA

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      F. HOFFMANN-LA ROCHE LTD.

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Illumina, Inc.

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Koninklijke Philips N.V.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      QIAGEN

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      Siemens Healthineers AG

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8      THERMO FISHER SCIENTIFIC INC.

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Products and Services

11.8.4     Financial Overview

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9      GE Healthcare

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Products and Services

11.9.4     Financial Overview

11.9.5     SWOT Analysis

11.9.6     Key Developments

11.10   Perspectum

11.10.1  Key Facts

11.10.2  Business Description

11.10.3  Products and Services

11.10.4  Financial Overview

11.10.5  SWOT Analysis

11.10.6  Key Developments

12.        Appendix

12.1      About The Insight Partners

12.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             China Liver Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 2.             China Liver Cancer Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)

Table 3.             China Liver Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 4.             Japan Liver Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 5.             Japan Liver Cancer Diagnostics Market, by Laboratory Tests– Revenue and Forecast to 2028 (USD Million)

Table 6.             Japan Liver Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 7.             India Liver Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             India Liver Cancer Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)

Table 9.             India Liver Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 10.          South Korea Liver Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 11.          South Korea Liver Cancer Diagnostics Market, by Laboratory Tests– Revenue and Forecast to 2028 (USD Million)

Table 12.          South Korea Liver Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 13.          Australia Liver Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 14.          Australia Liver Cancer Diagnostics Market, by Laboratory Tests– Revenue and Forecast to 2028 (USD Million)

Table 15.          Australia Liver Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 16.          Rest of APAC Liver Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 17.          Rest of APAC Liver Cancer Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)

Table 18.          Rest of APAC Liver Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 19.          Organic Developments in the Liver Cancer Diagnostics Market

Table 20.          Inorganic Developments in the Liver Cancer Diagnostics Market

Table 21.          Glossary of Terms

 


LIST OF FIGURES

Figure 1.           Asia Pacific Liver Cancer Diagnostics Market Segmentation

Figure 2.           Asia Pacific Liver Cancer Diagnostics Market Segmentation, By Country

Figure 3.           Asia Pacific Liver Cancer Diagnostics Market Overview

Figure 4.           Laboratory Tests Segment Held Largest Share by Type in Asia Pacific Liver Cancer Diagnostics Market

Figure 5.           China Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Asia Pacific Liver Cancer Diagnostics Market, Industry Landscape

Figure 7.           Asia Pacific: PEST Analysis

Figure 8.           Experts Opinion

Figure 9.           Impact Analysis of Drivers and Restraint Pertaining to Asia Pacific Liver Cancer Diagnostics Market

Figure 10.        Asia Pacific Liver Cancer Diagnostics Market – Revenue Forecast and Analysis – 2021- 2028

Figure 11.        Asia Pacific Liver Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)

Figure 12.        Laboratory Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Blood Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Biomarkers: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        : Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Imaging: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Biopsy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Others: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Asia Pacific Liver Cancer Diagnostics Market Revenue Share, By End User (2021 and 2028)

Figure 20.        Hospitals and Diagnostics Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Academic and Research Institutes: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        CRO Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Asia-Pacific: Liver Cancer Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 24.        Asia-Pacific: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 25.        China: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ MILLION)

Figure 26.        Japan: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        India: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        South Korea: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Australia: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Rest of APAC: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

The List of Companies - Asia Pacific Liver Cancer Diagnostics Market

  1. Abbott
  2. bioMerieux SA
  3. F. HOFFMANN-LA ROCHE LTD.
  4. Illumina, Inc.
  5. Koninklijke Philips N.V.
  6. QIAGEN
  7. Siemens Healthineers AG
  8. THERMO FISHER SCIENTIFIC INC.
  9. GE Healthcare
  10. Perspectum